IPF
-
Asset for Licensing: 11β-HSD1 Inhibitor, Oral QD candidate for MASH & IPF indications
If you are interested in these opportunities, please feel free to contact DrugTimes BD Team
-
创新药产品转让！11β-HSD1抑制剂，口服、每日一次，用于治疗MASH和IPF
欢迎感兴趣的药企立即联系药时代BD团队（BD@drugtimes.cn）！
-
Better Clinical Compound for Pulmonary IPF & PPF & ILD 【Product for Licensing】
If interested, please contact DrugTimes BD Team at BD@drugtimes.cn
-
TOP10 MNC Seeking FIC or BIC Products: IPF
If interested, please send an email message to BD@drugtimes.cn, and indicate the project ID in the subject line
-
TOP10 MNC Seeking FIC or BIC Products: Inflammatory bowel disease (IBD)
Project ID: BP-20240430-L-EE-81 About IBD Inflammatory bowel disease (IBD) is a gro…
-
2020年上半年：对抗新冠疫情大流行贯穿勃林格殷格翰的全球业务活动
公司采取各种措施来遏制和应对新冠疫情的全球蔓延公司的首要任务是保护员工并保障全球药品供应逆势而上，公司净销售额实现增长，但预计市场波动仍将剧烈 德国殷格翰，2020年8…
